| REGN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: REGN Market Cap History REGN YTD Return REGN RSI REGN DMA REGN MACD REGN Technical Analysis |
| REGN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+2.21% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| REGN Stock Price Chart |
| About Regeneron Pharmaceuticals, Inc. |
| Regeneron Pharmaceuticals is a biotechnology company. Co.'s products include: EYLEA, which is designed for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema, myopic choroidal neovascularization, diabetic retinopathy, neovascular glaucoma and retinopathy of prematurity; Dupixent, which is designed for the treatment of atopic dermatitis, asthma, rhinosinusitis with nasal polyposis, eosinophilic esophagitis (in adults and adolescents) and prurigo nodularis; and Libtayo, which is designed for the treatment of metastatic or locally advanced first-line non-small cell lung cancer and metastatic or recurrent second-line cervical cancer. We show 56 historical shares outstanding datapoints in our coverage of REGN's shares outstanding history. Understanding the changing numbers of Regeneron Pharmaceuticals shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like Regeneron Pharmaceuticals versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching Regeneron Pharmaceuticals by allowing them to research Regeneron Pharmaceuticals shares outstanding history as well as any other stock in our coverage universe. |
| REGN Current Stock Quote |
 Free REGN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| REGN Share Performance |
| Shares Outstanding Peers |
| Regeneron Pharmaceuticals (REGN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RENB Shares Outstanding History |
